Bernts L, Bruggemann R, Jansen A, Jager N, Wertheim H, Drenth J
J Antimicrob Chemother. 2024; 80(1):182-191.
PMID: 39508371
PMC: 11695873.
DOI: 10.1093/jac/dkae394.
Sharma B, Chalikwar R, Bhalerao S, Gondane A, Pawar D, Sharma A
Cureus. 2024; 16(9):e69146.
PMID: 39398799
PMC: 11467699.
DOI: 10.7759/cureus.69146.
Palmer L, Monteforte M, Smaldone G
Br J Clin Pharmacol. 2024; 91(1):127-133.
PMID: 39235040
PMC: 11671327.
DOI: 10.1111/bcp.16225.
Tsai D, Jamal J, Davis J, Lipman J, Roberts J
Clin Pharmacokinet. 2014; 54(3):243-60.
PMID: 25385446
DOI: 10.1007/s40262-014-0209-3.
Nath S, Foster G, Mandell L, Rotstein C
Can J Infect Dis. 2012; 6(1):21-7.
PMID: 22514377
PMC: 3327896.
DOI: 10.1155/1995/617610.
Protein binding: do we ever learn?.
Zeitlinger M, Derendorf H, Mouton J, Cars O, Craig W, Andes D
Antimicrob Agents Chemother. 2011; 55(7):3067-74.
PMID: 21537013
PMC: 3122431.
DOI: 10.1128/AAC.01433-10.
Clinical pharmacology and lesion penetrating properties of second- and third-line antituberculous agents used in the management of multidrug-resistant (MDR) and extensively-drug resistant (XDR) tuberculosis.
Dartois V, Barry C
Curr Clin Pharmacol. 2010; 5(2):96-114.
PMID: 20156156
PMC: 6344931.
DOI: 10.2174/157488410791110797.
Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killing.
Beer J, Wagner C, Zeitlinger M
AAPS J. 2009; 11(1):1-12.
PMID: 19117135
PMC: 2664873.
DOI: 10.1208/s12248-008-9072-1.
Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.
Muller M, dela Pena A, Derendorf H
Antimicrob Agents Chemother. 2004; 48(5):1441-53.
PMID: 15105091
PMC: 400530.
DOI: 10.1128/AAC.48.5.1441-1453.2004.
Effect of protein binding on penetration of beta-lactams into rabbit peripheral lymph.
Woodnutt G, Berry V, Mizen L
Antimicrob Agents Chemother. 1995; 39(12):2678-83.
PMID: 8593001
PMC: 163011.
DOI: 10.1128/AAC.39.12.2678.
Quinolones in the elderly.
Bergan T
Drugs. 1995; 49 Suppl 2:112-4.
PMID: 8549278
DOI: 10.2165/00003495-199500492-00017.
Beta-lactams versus glycopeptides in treatment of subcutaneous abscesses infected with Staphylococcus aureus.
Wood C, Wisniewski R
Antimicrob Agents Chemother. 1994; 38(5):1023-6.
PMID: 8067732
PMC: 188144.
DOI: 10.1128/AAC.38.5.1023.
Amikacin levels in bronchial secretions of 10 pneumonia patients with respiratory support treated once daily versus twice daily.
Santre C, Georges H, Jacquier J, Leroy O, Beuscart C, Buguin D
Antimicrob Agents Chemother. 1995; 39(1):264-7.
PMID: 7695320
PMC: 162523.
DOI: 10.1128/AAC.39.1.264.
Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).
PERITI P, Mazzei T, Mini E, Novelli A
Clin Pharmacokinet. 1989; 16(5):261-82.
PMID: 2663300
DOI: 10.2165/00003088-198916050-00001.
Effect of protein binding in serum on therapeutic efficacy of cephem antibiotics.
Tawara S, Matsumoto S, Kamimura T, Goto S
Antimicrob Agents Chemother. 1992; 36(1):17-24.
PMID: 1590685
PMC: 189219.
DOI: 10.1128/AAC.36.1.17.
Pharmacokinetic evaluation of ceftiofur in serum, tissue chamber fluid and bronchial secretions from healthy beef-bred calves.
Halstead S, Walker R, Baker J, Holland R, Stein G, Hauptman J
Can J Vet Res. 1992; 56(4):269-74.
PMID: 1477795
PMC: 1263555.
Serum and blister fluid pharmacokinetics and bactericidal activities of ampicillin-sulbactam, cefotetan, cefoxitin, ceftizoxime, and ticarcillin-clavulanate.
Jaresko G, Barriere S, JOHNSON Jr B
Antimicrob Agents Chemother. 1992; 36(10):2233-8.
PMID: 1444304
PMC: 245482.
DOI: 10.1128/AAC.36.10.2233.